MI-DSPACE
19.12.2023 14:07:34 CET | Business Wire | Press release
At CES 2024, dSPACE will show how electric and self-driving cars can get on the road faster with innovative development, simulation, and validation solutions. As the exclusive on-vehicle computer technology sponsor of the Indy Autonomous Challenge (IAC), dSPACE will demonstrate how dSPACE solutions work in demanding racing environments at the Autonomous Challenge @ CES 2024 night race at the Las Vegas Motor Speedway. Eight solutions will be presented at the dSPACE booth no. 4300 in the LVCC, West Hall. Here are some highlights:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231219166904/en/
At the Autonomous Challenge @ CES 2024, which will be held on January 11 at the Las Vegas Motor Speedway, nine teams comprised of 17 universities will compete against each other with fully autonomous racecars. Photo Credits: Indy Autonomous Challenge
E-mobility: Testing of battery management systems, power electronics, and technologies for intelligent charging
Battery management systems (BMS) are crucial for the smooth operation of lithium-ion batteries, and ensure the efficient use of available capacity, optimum temperatures, avoid overcharging as well as deep discharges, and thereby ensure safe operation and long life of the energy storage systems. dSPACE demonstrates a modular system design for the testing of battery management systems (BMS) that enables the testing of modern BMS. The system's field of application in the areas of development and validation range from battery systems for electric cars and planes to energy storage systems for modern power grids.
Power HIL systems from dSPACE are the first choice where inverters, including control and power electronics, have to be tested at full power. Designed specifically for hardware-in-the-loop (HIL) simulation at power level, they combine the flexibility of established HIL systems with full performance, enabling exceptionally precise testing of power electronics. The tests go well beyond endurance and also include testing the control behavior with different dynamic operating points of e-motors.
The Smart Charging Solution is a complete solution for the development and testing of intelligent charging technologies. The solution takes international standards into account, ensures interoperability analyses and tests, and supports developers of onboard chargers, charging stations, and, in future, inductive charging systems, robot charging, and megawatt charging for the truck and aviation sector with a comprehensive range of test options and dynamic models.
Autonomous driving: High-precision tests in the virtual world
The development of functions for highly automated and autonomous driving places increasingly strict requirements on the quality and safety of functions. Virtual tests are frontloaded to earlier development phases and executed by internationally distributed development teams. To meet these requirements, dSPACE has developed solutions such as SIMPHERA, the web-based, highly scalable cloud solution for simulation and virtual validation, and the AURELION sensor simulation. At CES, dSPACE will demonstrate how logical scenarios generated from measurement data can then be used for scenario-based testing in SIMPHERA. In this way, real recorded scenarios can later be used for virtual validation. In addition, it is shown how AURELION achieves a very high degree of realism in the simulation – by comparing the synthetic sensor simulation with the real recorded measurement data of the same scenario.
In a joint demonstration with AWS, dSPACE presents an intelligent fleet and data management environment that enables targeted data collection campaigns for the development and validation of ADAS/AD algorithms. The solution aims to drastically shorten the lead time for data acquisition from the definition of requirements to the availability of the recorded vehicle and sensor data in the data center, thereby increasing the efficiency of the data-driven development process.
The simulation of software stacks on high-performance computers (HPCs) in the newest E/E architectures for software-defined vehicles (SDVs) presents a particular challenge in software integration testing. In order to efficiently validate such systems, cloud-based software-in-the-loop environments are required that enable the simulation of the software components on HPCs based on real ARM processors together with those of the rest of the E/E architecture. To this end, dSPACE is working with AWS to offer an end-to-end solution based on dSPACE VEOS and AWS Graviton.
IAC: dSPACE technology during night racing and at the exhibition stand
At the Autonomous Challenge @ CES 2024, which will be held on January 11 at the Las Vegas Motor Speedway, nine teams comprised of 17 universities will compete against each other with fully autonomous racecars. CES visitors are invited to experience the action on the Las Vegas Motor Speedway. In addition, dSPACE is presenting its technologies for the IAC at booth 5901 in the exhibition area of the Las Vegas Convention Center (LVCC) West. A proven dSPACE component in the vehicles is the AUTERA AutoBox, the central onboard computer that manages all sensor data and performs the complex trajectory calculations. The IAC schedule for 2024 and other innovations will be presented on Monday, January 8, as part of the IAC press conference.
About dSPACE
dSPACE is a leading provider of simulation and validation solutions worldwide for developing networked, autonomous, and electrically powered vehicles. The company's range of end-to-end solutions are used particularly by automotive manufacturers and their suppliers to test the software and hardware components in their new vehicles long before a new model is allowed on the road. Not only is dSPACE a sought-after partner in vehicle development, engineers also rely on our know-how at dSPACE when it comes to aerospace and industrial automation. Our portfolio ranges from end-to-end solutions for simulation and validation to engineering and consulting services as well as training and support. With more than 2,500 employees worldwide, dSPACE is headquartered in Paderborn, Germany; has three project centers in Germany; and serves customers through its regional companies in the USA, the UK, France, Japan, China, Croatia, Korea, and India.
About the IAC
The Indy Autonomous Challenge (IAC) organizes racing competitions among university affiliated teams representing 17 universities from around the world to program fully autonomous racecars and compete in a series of history-making events at iconic tracks. Based in Indiana, the IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in safety and performance of automated vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, & YouTube.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231219166904/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse
Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release
Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
